📢📢 looking for a co-founder (CEO) for an early stage medtech startup‼️

Our goal: bring extracellular vesicles from the lab to the bedside of patients with chronic liver disease.🧪

Find the offer here: www.lesdeeptech.fr/tandem/41693...

📢📢 Analysis of 249 patients with MASLD and of 2 rat models:
⚠️Liver endothelial cell (LSEC) capillarisation appears before MASH onset
❌LSEC capillarisation progresses with liver fibrosis and inflammation
✅Lanifibranor improves LSEC function

authors.elsevier.com/sd/article/S...

Tips for managing invasive procedures in patients with cirrhosis 🩸🩸:
➡️What limits of laboratory values❓
➡️How to risk stratify procedures❓
➡️When to stop and restart anticoagulants and antiplatelet agents❓
Find this and more there:
doi.org/10.3350/cmh....

📢📢Interested in vascular liver diseases❓
Check the opportunities for:
✅Short Term Scientific Mission 🧳
Deadline Feb 21
✅Conference Grants
Deadline March 14

➡️ more details there
www.valdig.eu/cost-action-...

Hepato-pulmonary syndrome (HPS) in 196 patients with PSVD:
▶️prevalence: 7%
▶️risk factors: telomere biology disorders &
less preserved liver function
▶️outcome similar to PSVD patients w/o HPS when applying HPS MELD exception policy for transplantation
jhep-reports.eu/article/S258...